Trials / Conditions / Multiple Indications Cancer
Multiple Indications Cancer
3 registered clinical trials studyying Multiple Indications Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG NCT07295171 | British Columbia Cancer Agency | N/A |
| Withdrawn | Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Sq NCT03161613 | Bristol-Myers Squibb | — |
| Completed | Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib NCT02297139 | Bristol-Myers Squibb | Phase 2 |